Literature DB >> 19490831

Successful steroid pulse therapy for brain lesion caused by Shiga toxin 2 in rabbits.

Jun Fujii1, Yoshimasa Kinoshita, Akihiro Matsukawa, Sharon Y A M Villanueva, Takashi Yutsudo, Shin-ichi Yoshida.   

Abstract

Betamethasone sodium phosphate (BSP) is usually used as a steroid therapy for human brain edema. High doses of BSP (36mg/kg) twice a day for two days statistically reduced the mortality rate and improved the survival period of Stx2 (1.4mug/kg; 1.6LD(50))-toxemic rabbits. We made evaluations on three kinds of magnetic resonance images (MRI) including T1-weighted, T2-weighted, and enhanced MRI using gadopentetate dimeglumine (Gd-DTPA) to detect brain lesion induced by an intravenous injection of Stx2 in rabbits. Enhanced T1-weighted MRI was the most sensitive tool to find leakage of Gd-DTPA suggesting impairment of the blood brain barrier caused by Stx2. Enhanced MRI revealed that BSP treatment inhibited the leakage of Gd-DTPA, as directly evidenced by the protective effect of BSP against brain edema induced by intravenous injection of Stx2. Interleukin 1beta was not induced after Stx2 treatment in brain primary mixed cell culture.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490831     DOI: 10.1016/j.micpath.2009.01.005

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

Review 1.  Role of Shiga/Vero toxins in pathogenesis.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Microbiol Spectr       Date:  2014-06

2.  Central nervous system involvement in adults with epidemic hemolytic uremic syndrome.

Authors:  M Wengenroth; J Hoeltje; J Repenthin; T N Meyer; F Bonk; H Becker; S Faiss; O Stammel; P P Urban; R Bruening
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-10       Impact factor: 3.825

3.  Rescue from Stx2-Producing E. coli-Associated Encephalopathy by Intravenous Injection of Muse Cells in NOD-SCID Mice.

Authors:  Ryo Ozuru; Shohei Wakao; Takahiro Tsuji; Naoya Ohara; Takashi Matsuba; Muhammad Y Amuran; Junko Isobe; Morio Iino; Naoki Nishida; Sari Matsumoto; Kimiharu Iwadate; Noriko Konishi; Kaori Yasuda; Kosuke Tashiro; Misato Hida; Arisato Yadoiwa; Shinsuke Kato; Eijiro Yamashita; Sohkichi Matsumoto; Yoichi Kurozawa; Mari Dezawa; Jun Fujii
Journal:  Mol Ther       Date:  2019-10-01       Impact factor: 11.454

4.  Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli.

Authors:  Jorge Goldstein; Krista Nuñez-Goluboay; Alipio Pinto
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

5.  Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice.

Authors:  Muhammad Yunus Amran; Jun Fujii; Satoshi O Suzuki; Glynis L Kolling; Sharon Y A M Villanueva; Mosaburo Kainuma; Hideyuki Kobayashi; Hideko Kameyama; Shin-ichi Yoshida
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

6.  Chemokine expression in human astrocytes in response to shiga toxin 2.

Authors:  Naomi Kioka; Koichi Minami; Akira Tamura; Norishige Yoshikawa
Journal:  Int J Inflam       Date:  2012-12-10

7.  STEC:O111-HUS complicated by acute encephalopathy in a young girl was successfully treated with a set of hemodiafiltration, steroid pulse, and soluble thrombomodulin under plasma exchange.

Authors:  Noritaka Yada; Masayuki Fujioka; Charles L Bennett; Kazuya Inoki; Toyokazu Miki; Akihiko Watanabe; Toshiko Yoshida; Masaki Hayakawa; Masanori Matsumoto; Yoshihiro Fujimura
Journal:  Clin Case Rep       Date:  2015-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.